Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Wintermar Offshore Marine Tbk. (WINS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Wintermar Offshore Marine Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Wintermar Offshore Marine Tbk. diperdagangkan di Rp620 (kapitalisasi pasar 2,49 T, volume 24 jam 7,76 jt). Perbedaan utamanya: Wintermar Offshore Marine Tbk. jauh lebih besar — sekitar 23,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | WINS | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 2,49 T |
Volume | — | 7,76 jt |
Lot | — | 77,6 rb |
Perputaran | — | 4,7 M |
Harga Rata-rata | — | 606,21 |
Nilai Transaksi | — | 4,7 M |
Harga Ekuilibrium Indikatif | — | 620 |
Volume Ekuilibrium Indikatif | — | 3,81 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Wintermar Offshore Marine Tbk.
PT Wintermar Offshore Marine Tbk (the Company) was established under its original name of PT Swakarya Mulia Shipping base on notarial deed No.98 of Mrs Trisnawati Mulia, S.H, dated on 18 Dec, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 15 of Fathiah Helmi, S.H., dated Sep 16, 2010, concerning among others, change in company's name, par value and public offering.
Selengkapnya di halaman WINS →
